Detalhe da pesquisa
1.
Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC-MS/MS (liquid chromatography-tandem mass spectrometry) method for estrogen measurement.
Breast Cancer Res Treat
; 201(3): 425-435, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491651
2.
Monitoring serum estradiol levels in breast cancer patients during extended adjuvant letrozole treatment after five years of tamoxifen: a prospective trial.
Breast Cancer Res Treat
; 187(3): 769-775, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33710439
3.
Vaginal estradiol use and the risk for cardiovascular mortality.
Hum Reprod
; 31(4): 804-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26874358
4.
Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma.
Int J Cancer
; 137(8): 1947-52, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25846583
5.
[Treatment of menopausal symptoms]. / Nain hoidan vaihdevuosioireita.
Duodecim
; 131(16): 1515-21, 2015.
Artigo
em Fi
| MEDLINE | ID: mdl-26485945
6.
Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.
Int J Cancer
; 133(7): 1680-8, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23526244
7.
Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.
Int J Cancer
; 131(4): E537-43, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22024969
8.
A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.
Am J Epidemiol
; 175(4): 309-14, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22287638
9.
Primary fallopian tube carcinoma risk in users of postmenopausal hormone therapy in Finland.
Gynecol Oncol
; 126(2): 241-4, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22561401
10.
Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study.
Int J Cancer
; 128(7): 1644-51, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21280035
11.
Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas.
Gynecol Oncol
; 122(2): 260-3, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21531011
12.
[Hormone therapy and risk for breast cancer in Finnish postmenopausal women]. / Vaihdevuosi-iän hormonihoito ja rintasyöpäriski: uutta tietoa Suomesta.
Duodecim
; 127(3): 235-42, 2011.
Artigo
em Fi
| MEDLINE | ID: mdl-21438346
13.
Do the dose or route of administration of norethisterone acetate as a part of hormone therapy play a role in risk of breast cancer: national-wide case-control study from Finland.
Int J Cancer
; 127(1): 185-9, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19859914
14.
A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well.
Int J Cancer
; 126(2): 483-9, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19588504
15.
Breast cancer risk in postmenopausal women using estradiol-progestogen therapy.
Obstet Gynecol
; 113(1): 65-73, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19104361
16.
[Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative]. / Vaihdevuosien hormonihoito ja sydänkuolleisuus.
Duodecim
; 130(21): 2209, 2014.
Artigo
em Fi
| MEDLINE | ID: mdl-25582016
17.
Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland.
Cancer Epidemiol Biomarkers Prev
; 28(11): 1857-1860, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455672
18.
Breast cancer risk in postmenopausal women using estrogen-only therapy.
Obstet Gynecol
; 108(6): 1354-60, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17138766
19.
Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use.
Maturitas
; 94: 106-109, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27823727
20.
The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study.
Maturitas
; 81(3): 384-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25912424